drugset / Trial / NCT00119080
Effect of Meningococcal Conjugate Vaccine on Meningococcal Carriage
Phase 4
Completed
4000 enrolled
Centers for Disease Control and Prevention
Georgia Department of Human Resources · collabJohns Hopkins University · collabMaryland Department of Health and Mental Hygiene · collabUniversity of Pittsburgh · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this study is to determine whether the new meningococcal conjugate vaccine (MCV4) can reduce asymptomatic carriage of meningococcal bacteria, and thus decrease the transmission of these bacteria in the population.
Timeline
- Start
- 2006-08
- Primary completion
- —
- Completion
- 2007-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Menactra | Vaccine | — | — |